Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Share-based Compensation: 2023-2025

Historic Share-based Compensation for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $2.6 million.

  • Upstream Bio's Share-based Compensation rose 39.24% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 109.51%. This contributed to the annual value of $6.0 million for FY2024, which is 75.20% up from last year.
  • As of Q3 2025, Upstream Bio's Share-based Compensation stood at $2.6 million, which was down 0.12% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Share-based Compensation ranged from a high of $2.6 million in Q1 2025 and a low of $643,000 during Q1 2024.
  • Over the past 3 years, Upstream Bio's median Share-based Compensation value was $1.9 million (recorded in 2024), while the average stood at $1.7 million.
  • Data for Upstream Bio's Share-based Compensation shows a peak YoY skyrocketed of 309.80% (in 2025) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Share-based Compensation (Quarterly) stood at $813,000 in 2023, then spiked by 156.58% to $2.1 million in 2024, then soared by 39.24% to $2.6 million in 2025.
  • Its Share-based Compensation was $2.6 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.6 million in Q1 2025.